Literature DB >> 7477926

GABAergic axons in the ventral forebrain of the rat: an electron microscopic study.

H T Chang1, Q Tian, P Herron.   

Abstract

The ventral forebrain, including the ventral striatum, the ventral pallidum and the substantia innominata, is an important region involved in the functions of the basal ganglia and the limbic system, as well as the magnocellular corticopetal neurons of the nucleus basalis of Meynert. Although previous studies have shown that this region is richly innervated by GABAergic fibers, little is known with respect to the relative densities of GABAergic to non-GABAergic axon terminals in this region. To address this issue, we have developed a specific rabbit antiserum to GABA and used a postembedding immunocytochemical reaction to analyse the distribution of GABA-like immunoreactive axon terminals in the rat ventral striatum, ventral pallidum and substantia innominata. Of all axon terminals that form identifiable synapses within single ultrathin sections taken from these regions, 11.6% in the ventral striatum, 85.5% in the ventral pallidum and 64.8% in the substantia innominata were GABAergic. Differences were also found in the distribution patterns of these terminals with respect to the size of their synaptic target dendrites. These findings are consistent with previous findings that a majority of inputs to the ventral striatum are excitatory, and that a majority of inputs to the ventral pallidum are inhibitory. Our results provide a first approximation of the anatomical substrate for the physiology and pharmacology of GABA actions in the ventral forebrain region. These results also show that GABA may play an important role in the substantia innominata, where both the cholinergic and the non-cholinergic magnocellular corticopetal neurons reside within a neuropil innervated by many different non-cholinergic fibers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477926     DOI: 10.1016/0306-4522(95)00109-v

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior.

Authors:  A M Farrar; L Font; M Pereira; S Mingote; J G Bunce; J J Chrobak; J D Salamone
Journal:  Neuroscience       Date:  2008-01-01       Impact factor: 3.590

2.  Modulation of inhibitory transmission by dopamine in rat basal forebrain nuclei: activation of presynaptic D1-like dopaminergic receptors.

Authors:  T Momiyama; J A Sim
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus.

Authors:  M Vallée; W Mayo; M Darnaudéry; C Corpéchot; J Young; M Koehl; M Le Moal; E E Baulieu; P Robel; H Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Vesicular glutamate transporter 1 and vesicular glutamate transporter 2 synapses on cholinergic neurons in the sublenticular gray of the rat basal forebrain: a double-label electron microscopic study.

Authors:  E E Hur; R H Edwards; E Rommer; L Zaborszky
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

5.  Neurokinin-1 receptors in cholinergic neurons of the rat ventral pallidum have a predominantly dendritic distribution that is affected by apomorphine when combined with startle-evoking auditory stimulation.

Authors:  E Mengual; J Chan; D Lane; M San Luciano Palenzuela; Y Hara; A Lessard; V M Pickel
Journal:  Neuroscience       Date:  2007-12-04       Impact factor: 3.590

6.  Characterization of age-related changes in synaptic transmission onto F344 rat basal forebrain cholinergic neurons using a reduced synaptic preparation.

Authors:  William H Griffith; Dustin W Dubois; Annette Fincher; Kathryn A Peebles; Jennifer L Bizon; David Murchison
Journal:  J Neurophysiol       Date:  2013-10-16       Impact factor: 2.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.